Hisham Mohammed

Hisham Mohammed

Auto-generated profile, based on publicly available information

Hisham Mohammed

Oregon Health & Science University

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2015 in Nature
Verified
Journal Article
Open access
PDF file
HMHisham Mohammed
Hisham Mohammed
IRI. Alasdair Russell
I. Alasdair Russell
RSRory Stark
Rory Stark
OROscar M. Rueda
Oscar M. Rueda
THTheresa Elizabeth Hickey
Theresa Elizabeth Hickey
JCJason S. Carroll
Jason S. Carroll
Progesterone receptor (PR) expression is used as a biomarker of oestrogen receptor-α (ERα) function and breast cancer prognosis. Here we show that PR is not merely an ERα-induced gene target, but is also an ERα-associated protein that modulates its behaviour. In the presence of agonist ligands, PR associates with ERα to direct ERα chromatin binding events within breast cancer cells, resulting in a unique gene expression programme that is associated with good clinical outcome. Progesterone inhibited oestrogen-mediated growth of ERα+ cell line xenografts and primary ERα+ breast tumour explants, and had increased anti-proliferative effects when coupled with an ERα antagonist. Copy number loss of PGR, the gene coding for PR, is a common feature in ERα+ breast cancers, explaining lower PR levels in a subset of cases. Our findings indicate that PR functions as a molecular rheostat to control ERα chromatin binding and transcriptional activity, which has important implications for prognosis and therapeutic interventions.

1 February 2013 in Cell Reports
Verified
Journal Article
Open access
HMHisham Mohammed
Hisham Mohammed
CDClive D’sAntos
Clive D’sAntos
ASAurelien A. Serandour
Aurelien A. Serandour
HAH. Raza Ali
H. Raza Ali
GBGordon D. Brown
Gordon D. Brown
JCJason S. Carroll
Jason S. Carroll
Estrogen receptor-α (ER) is the driving transcription factor in most breast cancers, and its associated proteins can influence drug response, but direct methods for identifying interacting proteins have been limited. We purified endogenous ER using an approach termed RIME (rapid immunoprecipitation mass spectrometry of endogenous proteins) and discovered the interactome under agonist- and antagonist-liganded conditions in breast cancer cells, revealing transcriptional networks in breast cancer. The most estrogen-enriched ER interactor is GREB1, a potential clinical biomarker with no known function. GREB1 is shown to be a chromatin-bound ER coactivator and is essential for ER-mediated transcription, because it stabilizes interactions between ER and additional cofactors. We show a GREB1-ER interaction in three xenograft tumors, and using a directed protein-protein approach, we find GREB1-ER interactions in half of ER(+) primary breast cancers. This finding is supported by histological expression of GREB1, which shows that GREB1 is expressed in half of ER(+) cancers, and predicts good clinical outcome. These findings reveal an unexpected role for GREB1 as an estrogen-specific ER cofactor that is expressed in drug-sensitive contexts.

19 April 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ZJZongling Ji
Zongling Ji
HMHisham Mohammed
Hisham Mohammed
AWAaron Webber
Aaron Webber
JRJenna Ridsdale
Jenna Ridsdale
NHNamshik Han
Namshik Han
ASAndrew D. Sharrocks
Andrew D. Sharrocks
There are numerous forkhead transcription factors in mammalian cells but we know little about the molecular functions of the majority of these. FOXK2 is a ubiquitously expressed family member suggesting an important function across multiple cell types. Here, we show that FOXK2 binds to the SIN3A and PR-DUB complexes. The PR-DUB complex contains the important tumour suppressor protein, the deubiquitinase BAP1. FOXK2 recruits BAP1 to DNA, promotes local histone deubiquitination and causes changes in target gene activity. Our results therefore provide an important link between BAP1 and the transcription factor FOXK2 and demonstrate how BAP1 can be recruited to specific regulatory loci.

24 July 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
PLPaulina A. Latos
Paulina A. Latos
AGAngela Goncalves
Angela Goncalves
DODavid Oxley
David Oxley
HMHisham Mohammed
Hisham Mohammed
ETErnest Turro
Ernest Turro
MHMyriam Hemberger
Myriam Hemberger
Esrrb (oestrogen-related receptor beta) is a transcription factor implicated in embryonic stem (ES) cell self-renewal, yet its knockout causes intrauterine lethality due to defects in trophoblast development. Here we show that in trophoblast stem (TS) cells, Esrrb is a downstream target of fibroblast growth factor (Fgf) signalling and is critical to drive TS cell self-renewal. In contrast to its occupancy of pluripotency-associated loci in ES cells, Esrrb sustains the stemness of TS cells by direct binding and regulation of TS cell-specific transcription factors including Elf5 and Eomes. To elucidate the mechanisms whereby Esrrb controls the expression of its targets, we characterized its TS cell-specific interactome using mass spectrometry. Unlike in ES cells, Esrrb interacts in TS cells with the histone demethylase Lsd1 and with the RNA Polymerase II-associated Integrator complex. Our findings provide new insights into both the general and context-dependent wiring of transcription factor networks in stem cells by master transcription factors.

1 February 2012 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
BBBristi Basu
Bristi Basu
PSP. Correa de Sampaio
P. Correa de Sampaio
HMH. Mohammed
H. Mohammed
MFM. Fogarasi
M. Fogarasi
PCP. Corrie
P. Corrie
GMG. Murphy
G. Murphy

15 September 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
MJMaïka Jangal
Maïka Jangal
JCJean-Philippe Couture
Jean-Philippe Couture
SBStéphanie Bianco
Stéphanie Bianco
LMLuca Magnani
Luca Magnani
HMHisham Mohammed
Hisham Mohammed
NGNicolas Gévry
Nicolas Gévry
Chromatin constitutes a repressive barrier to the process of ligand-dependent transcriptional activity of nuclear receptors. Nucleosomes prevent the binding of estrogen receptor α (ERα) in absence of ligand and thus represent an important level of transcriptional regulation. Here, we show that in breast cancer MCF-7 cells, TLE3, a co-repressor of the Groucho/Grg/TLE family, interacts with FoxA1 and is detected at regulatory elements of ERα target genes in absence of estrogen. As a result, the chromatin is maintained in a basal state of acetylation, thus preventing ligand-independent activation of transcription. In absence of TLE3, the basal expression of ERα target genes induced by E2 is increased. At the TFF1 gene, the recruitment of TLE3 to the chromatin is FoxA1-dependent and prevents ERα and RNA polymerase II recruitment to TFF1 gene regulatory elements. Moreover, the interaction of TLE3 with HDAC2 results in the maintenance of acetylation at a basal level. We also provide evidence that TLE3 is recruited at several other regulatory elements of ERα target genes and is probably an important co-regulator of the E2 signaling pathway. In sum, our results describe a mechanism by which TLE3 affects ligand dependency in ERα-regulated gene expression via its binding restricting function and its role in gene regulation by histone acetylation.